fda semaglutide compounding news Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma roundup FDA says 'no clinical need'

The MHRA has issued safety communications on this issue

While semaglutide focuses only on the GLP-1 receptor, retatrutide also activates GIP and glucagon receptors, making it more comprehensive in promoting fat loss and improving metabolic health

Building on this success, the field has progressed toward dual and triple agonists to further enhance metabolic outcomes, exemplified by GLP-1/GIP co-agonists that deliver superior glycemic and weight control 1

You may be able to file an Ozempic lawsuit if you took compounded semaglutide and experienced serious complications such as hospitalization for gastrointestinal issues, unexpected psychiatric symptoms, or injury from overdosing or contaminated products

Duration of Treatment Interestingly, how long youve been taking semaglutide doesnt significantly change its half-life

Cardiovascular Exercise Low to moderate-intensity cardio supports overall caloric expenditure and cardiovascular health